Why Roche Holding Stock Popped Today
Roche Holding (OTC: RHHBY) stock jumped 3.4% through 1:05 p.m. ET Monday after the pharmaceutical giant's Genentech subsidiary announced positive phase 3 clinical trial results for its fenebrutinib drug for treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
Image source: Getty Images.
Conducted over more than 96 weeks, the first trial "significantly reduced the annualized relapse rate (ARR) compared to teriflunomide," an RMS drug developed by Sanofi and currently available as a generic from multiple manufacturers.
Source Fool.com
Roche Holding AG ADR Stock
€49.40
1.230%
Based on 4 Buy predictions and 3 Sell predictions the sentiment towards Roche Holding AG ADR is rather balanced.
On the other hand, the target price of 46 € is below the current price of 49.4 € for Roche Holding AG ADR, so the potential is actually -6.88%.
